Ready-to-use quality improvement tools for lung conditions
Official title: Developing an "Out of the Box" Quality Improvement Library for Lung Diseases
Funded at Phrase Health, INC. · NIH-11193804 · Data updated 2026-11-12
This project builds ready-made software templates hospitals can plug into their systems to help improve care for people with asthma, COPD, and other lung problems.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phrase Health, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 17, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $477,191 |
| NIH project number | 5R44HL172570-02 |
| Project ID | NIH-11193804 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with asthma, COPD, bronchiolitis, or other chronic lung conditions who receive care at hospitals or clinics using Phrase Health's Outcomes platform are the most likely to benefit.
✕Less likely to help
Patients treated at health systems that do not use these templates or those with very rare lung diseases not covered by the templates may not see any benefit.
What this research studies
From a patient point of view, the team is creating a library of pre-built quality-improvement templates that hospitals can use with clinical decision support to manage common lung conditions. They will convert two proven templates into standardized, easy-to-use packages and develop additional templates for other lung care needs. Hospitals using the software will get guided workflows to measure whether the templates improve care and to make data-driven adjustments. The goal is to make it simpler for quality-improvement teams of different experience levels to deliver consistent, evidence-informed care.
Why it matters
Potential benefit: If successful, this could help health systems provide more consistent, evidence-based treatment for asthma, COPD, and related lung conditions, potentially reducing flares and hospital visits.
How similar studies have gone: Clinical decision support and quality-improvement programs have improved outcomes in conditions like myocardial infarction and sickle cell disease, though results have been mixed and consistent system-level evaluation remains limited.
Where this research is happening
-
Phrase Health, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Tobias, Marc — Phrase Health, INC.
- Study coordinator: Tobias, Marc
Related research
Other NIH-funded projects on the same topics.
-
Clinical readiness for rare lung diseases (RLDC)
A group at the University of Cincinnati is building a program to speed up care for people with rare lung diseases by tracking patients over time, improving tests and treatments, and sharing information with patients and clinicians.
-
Epithelial cells trigger fibroblast activation in lung fibrosis through CTHRC1-TGFb signaling
A clinician-scientist at Duke is studying how lung lining cells may turn normal fibroblasts into fibrosis-causing cells, aiming to uncover new targets for treatment of diseases like BO and IPF.
-
Molecular origins of chronic lung diseases in the human lung
Researchers are mapping the tiny cell neighborhoods in diseased lungs to find early clues that could protect or restore normal lung function.
-
How lung cells and their surroundings drive fibrosis in interstitial lung diseases
A study to understand how airway cells, surrounding tissue, and their environment contribute to progressive scarring in interstitial lung diseases.
-
Loss of Cilia Maintenance in Acquired and Genetic Lung Diseases
Researchers are studying why tiny hair-like structures in the lungs lose their maintenance and how this affects people with asthma, COPD, and related airway diseases.
-
CMKLR1-targeted imaging to map lung inflammation in ALI and fibrotic lung diseases
A study to test a new PET imaging tool that targets CMKLR1 to visualize lung inflammation and help predict and monitor disease progression in patients with acute lung injury and fibrotic lung diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.